129 related articles for article (PubMed ID: 23194537)
1. A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.
Sagardia I; Roa-Ureta RH; Bald C
Food Chem; 2013 Feb; 136(3-4):1370-6. PubMed ID: 23194537
[TBL] [Abstract][Full Text] [Related]
2. Quantitative structure-activity relationship study of bitter di- and tri-peptides including relationship with angiotensin I-converting enzyme inhibitory activity.
Wu J; Aluko RE
J Pept Sci; 2007 Jan; 13(1):63-9. PubMed ID: 17117396
[TBL] [Abstract][Full Text] [Related]
3. New Quantitative Structure-Activity Relationship Model for Angiotensin-Converting Enzyme Inhibitory Dipeptides Based on Integrated Descriptors.
Deng B; Ni X; Zhai Z; Tang T; Tan C; Yan Y; Deng J; Yin Y
J Agric Food Chem; 2017 Nov; 65(44):9774-9781. PubMed ID: 28984136
[TBL] [Abstract][Full Text] [Related]
4. Structural determinants of RXPA380, a potent and highly selective inhibitor of the angiotensin-converting enzyme C-domain.
Georgiadis D; Cuniasse P; Cotton J; Yiotakis A; Dive V
Biochemistry; 2004 Jun; 43(25):8048-54. PubMed ID: 15209500
[TBL] [Abstract][Full Text] [Related]
5. Classification-based QSAR Models for the Prediction of the Bioactivity of ACE-inhibitor Peptides.
Tripaldi P; Pérez-González A; Rojas C; Radax J; Ballabio D; Todeschini R
Protein Pept Lett; 2018; 25(11):1015-1023. PubMed ID: 30430931
[TBL] [Abstract][Full Text] [Related]
6. Arachin derived peptides as selective angiotensin I-converting enzyme (ACE) inhibitors: structure-activity relationship.
Jimsheena VK; Gowda LR
Peptides; 2010 Jun; 31(6):1165-76. PubMed ID: 20214946
[TBL] [Abstract][Full Text] [Related]
7. Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? new insights from proline-rich peptides of Bothrops jararaca.
Ianzer D; Santos RA; Etelvino GM; Xavier CH; de Almeida Santos J; Mendes EP; Machado LT; Prezoto BC; Dive V; de Camargo AC
J Pharmacol Exp Ther; 2007 Aug; 322(2):795-805. PubMed ID: 17475904
[TBL] [Abstract][Full Text] [Related]
8. [Molecular descriptors of amino acids for the evaluation of the physicochemical parameters and biological activity of peptides].
Tiunina EIu; Badelin VG
Bioorg Khim; 2009; 35(4):501-9. PubMed ID: 19928052
[TBL] [Abstract][Full Text] [Related]
9. Novel ketomethylene inhibitors of angiotensin I-converting enzyme (ACE): inhibition and molecular modelling.
Redelinghuys P; Nchinda AT; Chibale K; Sturrock ED
Biol Chem; 2006 Apr; 387(4):461-6. PubMed ID: 16606345
[TBL] [Abstract][Full Text] [Related]
10. Structural requirements of Angiotensin I-converting enzyme inhibitory peptides: quantitative structure-activity relationship study of di- and tripeptides.
Wu J; Aluko RE; Nakai S
J Agric Food Chem; 2006 Feb; 54(3):732-8. PubMed ID: 16448176
[TBL] [Abstract][Full Text] [Related]
11. Modeling of the relationship between dipeptide structure and dipeptide stability, permeability, and ACE inhibitory activity.
Foltz M; van Buren L; Klaffke W; Duchateau GS
J Food Sci; 2009 Sep; 74(7):H243-51. PubMed ID: 19895477
[TBL] [Abstract][Full Text] [Related]
12. QSAR study on angiotensin-converting enzyme inhibitor oligopeptides based on a novel set of sequence information descriptors.
Wang X; Wang J; Lin Y; Ding Y; Wang Y; Cheng X; Lin Z
J Mol Model; 2011 Jul; 17(7):1599-606. PubMed ID: 20941517
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory profile of nonapeptide derived from porcine troponin C against angiotensin I-converting enzyme.
Katayama K; Tomatsu M; Kawahara S; Yamauchi K; Fuchu H; Kodama Y; Kawamura Y; Muguruma M
J Agric Food Chem; 2004 Feb; 52(4):771-5. PubMed ID: 14969529
[TBL] [Abstract][Full Text] [Related]
14. Chebulin: Terminalia chebula Retz. fruit-derived peptide with angiotensin-I-converting enzyme inhibitory activity.
Sornwatana T; Bangphoomi K; Roytrakul S; Wetprasit N; Choowongkomon K; Ratanapo S
Biotechnol Appl Biochem; 2015; 62(6):746-53. PubMed ID: 25410725
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanism of the interactions between inhibitory tripeptides and angiotensin-converting enzyme.
Zhou M; Du K; Ji P; Feng W
Biophys Chem; 2012 Jul; 168-169():60-6. PubMed ID: 22835627
[TBL] [Abstract][Full Text] [Related]
16. Modeling dipeptides as ACE inhibitors and bitter-tasting compounds by means of E-state structure-information representation.
Spasov B; Hall LH
Chem Biodivers; 2007 Nov; 4(11):2528-39. PubMed ID: 18027352
[TBL] [Abstract][Full Text] [Related]
17. Inhibition mechanism and model of an angiotensin I-converting enzyme (ACE)-inhibitory hexapeptide from yeast (Saccharomyces cerevisiae).
Ni H; Li L; Liu G; Hu SQ
PLoS One; 2012; 7(5):e37077. PubMed ID: 22606330
[TBL] [Abstract][Full Text] [Related]
18. SVEEVA descriptor application to peptide QSAR.
Tong J; Che T; Liu S; Li Y; Wang P; Xu X; Chen Y
Arch Pharm (Weinheim); 2011 Nov; 344(11):719-25. PubMed ID: 21956614
[TBL] [Abstract][Full Text] [Related]
19. [Synthesis and activity of ACE inhibitory peptides].
Ren J; Cao G; Zhang RJ; Li DW; Wei TT; Qin CG
Yao Xue Xue Bao; 2011 Jan; 46(1):58-63. PubMed ID: 21465810
[TBL] [Abstract][Full Text] [Related]
20. Latent production of angiotensin I-converting enzyme inhibitors from buckwheat protein.
Li CH; Matsui T; Matsumoto K; Yamasaki R; Kawasaki T
J Pept Sci; 2002 Jun; 8(6):267-74. PubMed ID: 12093003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
